Responses
Treatment
Original article
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.